Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
2.22
Dollar change
+0.03
Percentage change
1.37
%
Index- P/E115.63 EPS (ttm)0.02 Insider Own5.38% Shs Outstand89.54M Perf Week-13.62%
Market Cap198.78M Forward P/E- EPS next Y-0.18 Insider Trans0.00% Shs Float84.72M Perf Month10.45%
Income1.60M PEG- EPS next Q0.03 Inst Own14.36% Short Float1.67% Perf Quarter38.75%
Sales59.85M P/S3.32 EPS this Y66.67% Inst Trans-3.01% Short Ratio1.99 Perf Half Y26.86%
Book/sh0.68 P/B3.29 EPS next Y-160.71% ROA1.67% Short Interest1.41M Perf Year1.83%
Cash/sh1.26 P/C1.76 EPS next 5Y-3.82% ROE2.81% 52W Range1.35 - 3.03 Perf YTD45.10%
Dividend Est.- P/FCF- EPS past 5Y12.14% ROI2.54% 52W High-26.74% Beta2.97
Dividend TTM- Quick Ratio4.14 Sales past 5Y142.78% Gross Margin84.53% 52W Low64.44% ATR (14)0.16
Dividend Ex-Date- Current Ratio4.14 EPS Y/Y TTM105.31% Oper. Margin17.67% RSI (14)51.65 Volatility8.53% 7.83%
Employees68 Debt/Eq0.05 Sales Y/Y TTM698.03% Profit Margin2.67% Recom1.00 Target Price4.00
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q112.72% Payout- Rel Volume0.57 Prev Close2.19
Sales Surprise1235.94% EPS Surprise110.53% Sales Q/Q- EarningsNov 12 BMO Avg Volume711.03K Price2.22
SMA20-5.25% SMA5015.40% SMA20019.28% Trades Volume407,362 Change1.37%
Date Action Analyst Rating Change Price Target Change
Jan-13-25Initiated Oppenheimer Outperform $4
Aug-05-22Downgrade Jefferies Buy → Hold $2
May-26-20Resumed JMP Securities Mkt Outperform $18
May-13-20Initiated Stifel Buy $19
May-07-20Initiated SVB Leerink Outperform
Apr-22-20Initiated ROTH Capital Buy $28
Mar-24-20Initiated SunTrust Buy $16
Jan-16-20Initiated Cantor Fitzgerald Overweight $10
Mar-29-18Initiated Oppenheimer Outperform
Feb-01-16Resumed Oppenheimer Outperform
Feb-04-25 07:00AM
Jan-08-25 07:00AM
Nov-27-24 07:00AM
Nov-13-24 02:08AM
Nov-12-24 11:05AM
09:56AM Loading…
09:56AM
07:00AM
Nov-11-24 07:00AM
Nov-05-24 09:00AM
Oct-29-24 07:00AM
Oct-07-24 07:00AM
Sep-11-24 12:00PM
Sep-09-24 07:00AM
Aug-29-24 07:00AM
Aug-26-24 12:20PM
08:25AM Loading…
Aug-06-24 08:25AM
07:22AM
07:00AM
Jul-30-24 06:52AM
Jul-29-24 07:00AM
Jul-23-24 07:00AM
Jun-17-24 07:00AM
Jun-04-24 09:55AM
May-30-24 07:00AM
May-21-24 08:08AM
May-20-24 11:52AM
08:10AM
07:07AM
07:00AM
May-16-24 07:00AM
09:57AM Loading…
May-15-24 09:57AM
07:00AM
May-06-24 07:00AM
Apr-25-24 07:00AM
Apr-10-24 07:00AM
Apr-03-24 07:00AM
Mar-12-24 12:00PM
Mar-11-24 07:00AM
Mar-07-24 09:41AM
Mar-06-24 07:00AM
Mar-05-24 11:53AM
07:16AM
07:00AM
Feb-29-24 08:58AM
Feb-26-24 07:00AM
Feb-21-24 12:00PM
Feb-20-24 07:00AM
Feb-15-24 07:00AM
Jan-08-24 07:05AM
07:00AM
Dec-19-23 10:11AM
07:10AM
07:05AM
07:00AM
Dec-15-23 08:17AM
Dec-05-23 09:40AM
Nov-08-23 04:41PM
Nov-07-23 07:28AM
07:00AM
Nov-06-23 07:00AM
Nov-03-23 04:35PM
Oct-31-23 09:00AM
Oct-24-23 07:00AM
Oct-03-23 07:00AM
Oct-02-23 07:00AM
Sep-27-23 09:00AM
Sep-14-23 09:40AM
Aug-31-23 07:00AM
Aug-29-23 09:40AM
Aug-10-23 12:13PM
Aug-07-23 07:17AM
07:00AM
Jul-24-23 07:00AM
Jul-17-23 07:00AM
Jun-22-23 07:00AM
Jun-13-23 07:00AM
Jun-05-23 07:00AM
Jun-02-23 07:09AM
May-25-23 10:49AM
May-18-23 09:40AM
May-15-23 07:10AM
07:00AM
May-11-23 07:00AM
May-09-23 07:00AM
May-01-23 07:00AM
Apr-27-23 07:00AM
Apr-26-23 07:00AM
Mar-15-23 07:00AM
Mar-14-23 09:40AM
Mar-13-23 06:30AM
Mar-10-23 02:08AM
Mar-08-23 07:00AM
Mar-06-23 07:00AM
Feb-28-23 12:17PM
Feb-27-23 07:00AM
Feb-14-23 07:00AM
Feb-13-23 07:00AM
Feb-09-23 07:00AM
Feb-08-23 05:25PM
Jan-27-23 09:32AM
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.